Ming Chen, PhD
Zhejiang Cancer Hospital
5
2
1
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Xianghui Du, MD
Zhejiang Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
weiguo zhu, MD
Huai'an First People's Hospital
Shared therapeutic areas:
Worked with same sponsors:
youngling JI, MD
Zhejiang Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
Guangying Zhu, PhD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Tingyi Xia, PhD
Chinese PLA General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jinming Yu, PhD
Shandong Cancer Hospital and Institute
Shared therapeutic areas:
Worked with same sponsors:
Qibin Song, PhD
Renmin Hospital of Wuhan University
Shared therapeutic areas:
Worked with same sponsors:
Conghua Xie, PhD
Zhongnan Hospital
Shared therapeutic areas:
Worked with same sponsors:
Jiancheng Li, PhD
Fujian Province Cancer Hospital
Shared therapeutic areas:
Worked with same sponsors:
Zhengfei Zhu, PhD
Fudan University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Rituximab Combined With Chidamide and Lenalidomide for r/r AITL
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)
A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma
All 5 trials loaded